According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Chronic Myeloid Leukemia (CML) affects millions worldwide, including a rising number in India. Effective management involves ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

A four-year, $1.2 million grant from the National Cancer Institute of the National Institutes of Health may help researchers ...

The burden of cancer can blow up even the best-laid plans. More than two million people in the U.S. are expected to be ...

Hemogenyx Pharmaceuticals plc has developed a new and improved version of its bispecific antibody CDX for the treatment of relapsed/refractory acute myeloid leukemia, a subset of acute lymphoblastic ...

Activation of macrophage TLR4 by bacterial endotoxins is important for the progression of sepsis, but the underlying ...

They’re both just so positive. Both of them are always smiling.” Westford girls soccer coach Tracy Capone on defenders Ali ...

Good day, everyone, and welcome to Affimed Second Quarter 2024 Earnings and Corporate Update Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, ...

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...